Robitussin cough syrup supplied nationally is being recalled by Haleon owing to microbial contamination that may cause fatal infections in susceptible individuals, the US division of the global consumer health company based in the UK announced this week.
"Use of the recalled products could potentially result in severe or life-threatening fungal infections in those with impaired immune systems," Haleon stated in a notice posted by the Food and Drug Administration, according to CBS.
"Most users are unlikely to experience a serious health problem, but an infection that requiring medical intervention can't be ruled out," the company said.
Robitussin is frequently used to treat respiratory allergies, the common cold, the flu, and hay fever. The following goods are included in the recall, along with their lot numbers and expiration dates:
Robitussin Honey CF Max Day Adult 4oz — T10810 — October 31, 2025
Robitussin Honey CF Max Day Adult 8oz — T08730, T08731, T08732, T08733 — May 31, 2025
Robitussin Honey CF Max Day Adult 8oz — T10808 — September 30, 2025
Robitussin Honey CF Max NT Adult 8oz — T08740, T08742 — June 30, 2026
"Consumers who purchased the recalled products shouldn't use them," Haleon said.
Regulatory authority sends summary to increase the prices of gas to federal govt
Benchmark index sheds 1,308.73 points, or -1.13%, settling at 114,860.68
Next hike in inflation would not be concerning as it would stabilise afterwards, says Jameel Ahmed
MPC says deceleration mainly driven by continued decline in food inflation while "outlook susceptible to risks"
Bitcoin surged over 50% since Trump's Nov 5 election win along with many other pro-crypto candidates
Benchmark KSE-100 Index rises by 1,867.61 points, or 1.63%, to close at 116,681.59 points
